Khurshid Ahmed Khan
Overview
Explore the profile of Khurshid Ahmed Khan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suleman K, Mushtaq A, Haque E, Badran A, Ajarim D, Elashwah A, et al.
Breast Care (Basel)
. 2021 Mar;
16(1):59-65.
PMID: 33716633
Introduction: Human epidermal growth factor receptor 2 (HER-2) targeted therapy regimens can improve tumor response in HER-2-positive metastatic breast cancer (MBC), with overall survival benefits. Objective: We evaluated the efficacy...
2.
Khan Chachar A, Khan K, Iqbal J, Shahid A, Asif M, Fatima S, et al.
Ann Med Surg (Lond)
. 2021 Feb;
63:102165.
PMID: 33585031
Background: The first case of Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was diagnosed in Wuhan, China in 2019. In the first half of 2020, this disease has...
3.
Afreen B, Khan K, Riaz A
J Ayub Med Coll Abbottabad
. 2017 Oct;
29(3):428-431.
PMID: 29076676
Background: Adrenal insufficiency (AI) is the most common endocrine complication among patients with AIDS/HIV infection and there are number of causes of AI in HIV patients. Human immunodeficiency virus directly...
4.
Malik U, Mahmood N, Khan K, Hameed M, Randhawa F, Salman S, et al.
J Ayub Med Coll Abbottabad
. 2017 Jul;
29(1):102-106.
PMID: 28712186
Background: Among five main pillars of Islam Fasting is one of the key elements, all healthy adult Muslims have to observe fast from dawn till dusk during the holy month...
5.
Hafiz A, Abbasi A, Ali N, Khan K, Qureshi B
J Coll Physicians Surg Pak
. 2015 Nov;
25(11):802-6.
PMID: 26577965
Objective: To determine the frequency and severity of acute toxicity of pelvic radiotherapy for gynecological cancer. Study Design: A case series. Place And Duration Of Study: Department of Oncology, The...
6.
Khan K, Abbasi A, Ali N
J Coll Physicians Surg Pak
. 2014 Dec;
24(12):935-9.
PMID: 25523732
Anaplastic Oligodendroglioma / Anaplastic Oligoastrocytoma (AO/AOA) is a WHO Grade-III primary brain tumor. These tumors comprise about 5 - 10% of all gliomas, which make them the third most common...
7.
Abbasi A, Hafiz A, Ali N, Khan K
Asian Pac J Cancer Prev
. 2013 Dec;
14(10):5989-93.
PMID: 24289613
Background: Radiation therapy is the mainstay of treatment for nasopharyngeal carcinoma. Importance of tumor coverage and challenges posed by its unique and critical location are well evident. Therefore we aimed...
8.
Abbasi M, Mahmood H, Faheem M, Khan K, Irfan J
J Coll Physicians Surg Pak
. 2012 Apr;
22(5):333-4.
PMID: 22538044
Carcinosarcoma of the breast is an extremely rare and aggressive tumour with two distinct cell lines comprising epithelial and mesenchymal components, with few cases reported in the literature. The prognosis...
9.
Khan K, Siddiqui N, Junaid A, Siddiqui S
J Coll Physicians Surg Pak
. 2008 Sep;
18(9):576-7.
PMID: 18803898
The spectrum of plasma cell neoplasm represents indolent conditions like Monoclonal Gammopathy of Undetermined Significance (MGUS) to more aggressive multiple myeloma and plasma cell leukemia. Non-secretory myeloma comprises less than...
10.
Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia
Khan K, Junaid A, Siddiqui N, Mukhtar K, Siddiqui S
J Coll Physicians Surg Pak
. 2008 May;
18(3):176-8.
PMID: 18460249
Imatinib mesylate is a BCR-ABL tyrosine kinase inhibitor used in the management of chronic myeloid leukemia. It is a safe and well-tolerated agent with a few manageable side effects. We...